Hosted on MSN1d
Genetic Risk Predictor Might Boost Detection of Undiagnosed COPD
If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...
News Medical on MSN2d
COPD is the sixth leading cause of death in the US
Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...
Too Old to Operate10h
Machine Learning-Based Speech Analysis to Predict COPD Status
The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...
Amarillo Globe-News on MSN3d
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patients
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
pulmonologyadvisor1d
In COPD Treatment, Tezepelumab Not Linked to Reduced Exacerbations
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
healthday6h
Injurious Falls Common in Last Years of Life With COPD
Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before de ...
Rolling Out6d
Conquering COPD through movement and resilience
Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...
Rolling Out10d
Why COPD affects women differently
The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...
EurekAlert!2d
COPD is the sixth leading cause of death in the United States
Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...
The Financial Express4d
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
emjreviews.com1d
New Decision Tool Improves COPD Outcomes While Reducing Antibiotics
Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...
Healio1d
Risk for cardiovascular events stays high 1 year after COPD exacerbation
Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...